For members whose medical carrier is one company but whose behavioral-health benefits are administered by Magellan Healthcare — a Centene subsidiary, common in public-sector employer plans and self-funded employer benefit structures. We verify your Magellan benefits, file prior authorization, and advocate through peer-to-peer review and state-specific external appeals when the level of care your clinical assessment supports is challenged.
In most cases, yes. Magellan Healthcare is one of the largest specialty behavioral-health benefit administrators in the United States — particularly common in public-sector employer plans, self-funded employer benefits, and Medicaid managed-care lines. Magellan was acquired by Centene Corporation in January 2022 and now operates as a Centene subsidiary while keeping the Magellan brand for behavioral-health benefit administration. Most Magellan-managed plans cover medical detox, residential treatment, MAT, partial hospitalization, intensive outpatient, and structured aftercare. Our utilization-review team verifies your Magellan benefits and sends a written breakdown — covered levels of care, expected length-of-stay authorization, and any cost-sharing — typically within 30 minutes.
If your medical card lists one carrier (BCBS, Aetna, etc.) but the behavioral-health or mental-health section names Magellan, this is the verification path that applies to you.
Magellan administers behavioral-health benefits across a wide range of plan structures. Specifics depend on the underlying employer or government plan, but Magellan’s utilization-management framework standardizes most authorization decisions. Typical authorization windows we see:
Specific authorization length depends on your plan, the clinical assessment at intake, and concurrent-review decisions Magellan’s utilization-management team makes during your stay. Each review window is met with documentation that supports the level of care.
Authorization tells you what’s covered; the program decides whether it works. Magellan-managed members often work in public-sector roles or large self-funded employer plans — they need a treatment center fluent in the carve-out structure without dropping the clinical work.
Authorization gets you in the door. The clinical, family, and aftercare work decides whether you stay out.
Magellan-managed cases follow a slightly different workflow than primary-carrier-administered cases. Verification splits between Magellan (for behavioral-health-side benefits) and your medical-side carrier (for any medical-and-surgical components, including MAT prescription benefits). Our utilization-review and billing team handles both sides of the split — and the full Magellan UM cycle from intake through external appeal.
The decision to escalate is not commercial. It’s clinical. When a client is denied care that’s clinically indicated, we advocate for them — through every step above — to support coverage of the level of care our team believes is medically appropriate.
Magellan-managed plans are governed by federal law plus the regulatory framework of the underlying medical plan and the state in which it’s domiciled.
When we appeal a Magellan denial, the appeal is built on the clinical documentation, federal MHPAEA, and the state insurance law applicable to your underlying plan. All three matter.
Industry standard says 28 days. The clinical literature on substance-use treatment outcomes says something different. The National Institute on Drug Abuse, summarizing decades of research in its Principles of Effective Treatment, states that participation in treatment for less than 90 days is of limited effectiveness for most substance-use disorders, and that better outcomes are associated with longer durations of treatment. This includes time across the full continuum — detox, residential, PHP, IOP, and continuing care.
This is why we build for length-of-stay flexibility. Some Magellan-managed members need a focused inpatient stay because of work or family constraints, then continue at PHP or IOP. Others — those with severe withdrawal risk, complex psychiatric comorbidity, or chronic relapse history — need extended residential care. The right length of stay is a clinical decision, not a calendar decision.
When concurrent review tries to cut a stay short, our UR and medical teams document the clinical reasoning, file the peer-to-peer request, and pursue appeals — including the state-specific external-review pathway — when warranted.
Magellan administers behavioral-health benefits for a wide range of plan structures. Some of the populations whose plans we commonly verify:
If your card or plan documents reference Magellan Healthcare, Magellan Health, or Magellan Behavioral Health, our UR team can walk through the verification with you.
Three steps. No commitment.
In most cases, yes. Magellan administers behavioral-health benefits for many employer plans, public-sector benefits, and Medicaid managed-care lines. Most Magellan-managed plans cover medical detox, residential treatment, MAT, PHP, IOP, and aftercare.
A carve-out is a benefit structure where your medical-and-surgical benefits are administered by one carrier (BCBS, Aetna, Cigna, etc.) and your behavioral-health and substance-use benefits are administered separately by a specialty behavioral-health company like Magellan.
Centene Corporation acquired Magellan Healthcare in January 2022. Magellan continues to operate as a Centene subsidiary while keeping the Magellan brand for behavioral-health benefit administration. From a member perspective, the verification process and benefit structure haven’t changed since the acquisition.
Most Magellan-managed plans cover medical detox when medically indicated. Authorization windows we typically see are 3 to 12 days, depending on substance, withdrawal severity, and medical or psychiatric complexity.
Most Magellan-managed plans require prior authorization for medical detox and residential admission. Our UR team files the prior-auth request with clinical documentation supporting medical necessity, typically before admission.
Our medical director conducts a peer-to-peer review with Magellan’s medical director. If the denial holds, we file Level-1 and Level-2 internal appeals. When internal appeals are exhausted, we handle external appeals through the appropriate state-specific or ERISA-track pathway based on your underlying plan’s regulatory framework.
Most Magellan-managed plans cover MAT for opioid use disorder (buprenorphine, naltrexone) and alcohol use disorder (naltrexone, acamprosate) when prescribed as part of a clinical treatment plan. The prescription benefit is typically administered by your medical-side carrier’s PBM rather than Magellan directly.
Most Magellan-managed plans cover treatment of co-occurring psychiatric conditions alongside substance-use treatment when both are clinically indicated, per federal MHPAEA parity requirements.
Call once. We pull the Magellan benefits, file what needs to be filed, and walk you through what’s covered. Verification is free, confidential, and not a commitment to admit.
All Magellan Healthcare and Centene trademarks remain with their owners. This page exists to explain coverage, not to claim affiliation. Insurance acceptance is subject to benefit verification. Treatment outcomes vary by individual; statements about the authorization, peer-to-peer, and appeals process describe Gev’s Recovery’s standard practices and do not guarantee specific coverage decisions by your plan. Gev’s Recovery Center · 19448 Lassen St, Northridge, CA 91324 · CA DHCS license #191288AP.
